MII IG Kerndatensatz-Modul Molekulares Tumorboard
2026.0.0 - release
Unknown region code '276'
MII IG Kerndatensatz-Modul Molekulares Tumorboard, published by Medizininformatik-Initiative. This guide is not an authorized publication; it is the continuous build for version 2026.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/medizininformatik-initiative/kerndatensatzmodul-molekulares-tumorboard/ and changes regularly. See the Directory of published versions
@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
# - resource -------------------------------------------------------------------
a fhir:MedicationRequest ;
fhir:nodeRole fhir:treeRoot ;
fhir:id [ fhir:v "mii-exa-mtb-medication-request-mirvetuximab"] ; #
fhir:meta [
( fhir:profile [
fhir:v "https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/StructureDefinition/mii-pr-mtb-therapieempfehlung|2026.0.0"^^xsd:anyURI ;
fhir:l <https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/StructureDefinition/mii-pr-mtb-therapieempfehlung?version=2026.0.0> ] )
] ; #
fhir:text [
fhir:status [ fhir:v "extensions" ] ;
fhir:div [ fhir:v "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: MedicationRequest mii-exa-mtb-medication-request-mirvetuximab</b></p><a name=\"mii-exa-mtb-medication-request-mirvetuximab\"> </a><a name=\"hcmii-exa-mtb-medication-request-mirvetuximab\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-mii-pr-mtb-therapieempfehlung.html\">MII PR MTB Therapieempfehlung Systemische Therapieversion: null2026.0.0)</a></p></div><p><b>MII EX MTB Empfehlung Priorität</b>: 1</p><p><b>MII EX MTB Empfehlung Evidenzgraduierung</b>: <span title=\"Codes:{https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/CodeSystem/mii-cs-mtb-empfehlung-evidenzgrad m1A}\">m1A</span></p><p><b>MII EX MTB Empfehlung Publikation</b>: <code>http://doi.org</code>/10.1200/JCO.2022.40.16_suppl.5512</p><p><b>MII EX MTB Empfehlung Publikation</b>: <code>http://www.ncbi.nlm.nih.gov/pubmed</code>/38055253</p><p><b>status</b>: Completed</p><p><b>intent</b>: Proposal</p><p><b>medication</b>: <span title=\"Codes:{http://fdasis.nlm.nih.gov 98DE7VN88D}, {http://fhir.de/CodeSystem/bfarm/atc L01FX26}, {http://fhir.de/CodeSystem/bfarm/atc L01FX}\">MIRVETUXIMAB SORAVTANSINE</span></p><p><b>subject</b>: <a href=\"Patient-PatientKimMusterperson.html\">Kim Musterperson (no stated gender), DoB: 1956-03-14</a></p><p><b>authoredOn</b>: 2023-03-28</p><p><b>reasonReference</b>: <a href=\"Condition-PatientKimMusterperson-PrimaryDiagnosis-2.html\">Condition Bösartige Neubildung: Peritoneum, nicht näher bezeichnet</a></p><p><b>basedOn</b>: <a href=\"CarePlan-mii-exa-mtb-kim-musterperson-therapieplan.html\">CarePlan: status = active; intent = plan; category = prätherapeutische Tumorkonferenz (Festlegung der Therapiestrategie); created = 2023-03-28</a></p></div>"^^rdf:XMLLiteral ]
] ; #
fhir:extension ( [
fhir:url [
fhir:v "https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/StructureDefinition/mii-ex-mtb-empfehlung-prioritaet"^^xsd:anyURI ;
fhir:l <https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/StructureDefinition/mii-ex-mtb-empfehlung-prioritaet> ] ;
fhir:value [
a fhir:PositiveInt ;
fhir:v "1"^^xsd:positiveInteger ]
] [
fhir:url [
fhir:v "https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/StructureDefinition/mii-ex-mtb-empfehlung-evidenzgraduierung"^^xsd:anyURI ;
fhir:l <https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/StructureDefinition/mii-ex-mtb-empfehlung-evidenzgraduierung> ] ;
fhir:value [
a fhir:CodeableConcept ;
( fhir:coding [
fhir:system [
fhir:v "https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/CodeSystem/mii-cs-mtb-empfehlung-evidenzgrad"^^xsd:anyURI ;
fhir:l <https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/CodeSystem/mii-cs-mtb-empfehlung-evidenzgrad> ] ;
fhir:code [ fhir:v "m1A" ] ] ) ]
] [
fhir:url [
fhir:v "https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/StructureDefinition/mii-ex-mtb-empfehlung-publikation"^^xsd:anyURI ;
fhir:l <https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/StructureDefinition/mii-ex-mtb-empfehlung-publikation> ] ;
fhir:value [
a fhir:Identifier ;
fhir:system [
fhir:v "http://doi.org"^^xsd:anyURI ;
fhir:l <http://doi.org> ] ;
fhir:value [ fhir:v "10.1200/JCO.2022.40.16_suppl.5512" ] ]
] [
fhir:url [
fhir:v "https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/StructureDefinition/mii-ex-mtb-empfehlung-publikation"^^xsd:anyURI ;
fhir:l <https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/StructureDefinition/mii-ex-mtb-empfehlung-publikation> ] ;
fhir:value [
a fhir:Identifier ;
fhir:system [
fhir:v "http://www.ncbi.nlm.nih.gov/pubmed"^^xsd:anyURI ;
fhir:l <http://www.ncbi.nlm.nih.gov/pubmed> ] ;
fhir:value [ fhir:v "38055253" ] ]
] ) ; #
fhir:status [ fhir:v "completed"] ; #
fhir:intent [ fhir:v "proposal"] ; #
fhir:medication [
a fhir:CodeableConcept ;
( fhir:coding [
fhir:system [
fhir:v "http://fdasis.nlm.nih.gov"^^xsd:anyURI ;
fhir:l <http://fdasis.nlm.nih.gov> ] ;
fhir:code [ fhir:v "98DE7VN88D" ] ;
fhir:display [ fhir:v "MIRVETUXIMAB SORAVTANSINE" ] ] [
fhir:system [
fhir:v "http://fhir.de/CodeSystem/bfarm/atc"^^xsd:anyURI ;
fhir:l <http://fhir.de/CodeSystem/bfarm/atc> ] ;
fhir:version [ fhir:v "2025" ] ;
fhir:code [ fhir:v "L01FX26" ] ;
fhir:display [ fhir:v "Mirvetuximab soravtansin" ] ] [
fhir:system [
fhir:v "http://fhir.de/CodeSystem/bfarm/atc"^^xsd:anyURI ;
fhir:l <http://fhir.de/CodeSystem/bfarm/atc> ] ;
fhir:version [ fhir:v "2025" ] ;
fhir:code [ fhir:v "L01FX" ] ;
fhir:display [ fhir:v "Andere monoklonale Antikörper und Antikörper-Wirkstoff-Konjugate" ] ] )
] ; #
fhir:subject [
fhir:l fhir:Patient/PatientKimMusterperson ;
fhir:reference [ fhir:v "Patient/PatientKimMusterperson" ]
] ; #
fhir:authoredOn [ fhir:v "2023-03-28"^^xsd:date] ; #
fhir:reasonReference ( [
fhir:l fhir:Condition/PatientKimMusterperson-PrimaryDiagnosis-2 ;
fhir:reference [ fhir:v "Condition/PatientKimMusterperson-PrimaryDiagnosis-2" ]
] ) ; #
fhir:basedOn ( [
fhir:l fhir:CarePlan/mii-exa-mtb-kim-musterperson-therapieplan ;
fhir:reference [ fhir:v "CarePlan/mii-exa-mtb-kim-musterperson-therapieplan" ]
] ) . #
IG © 2024+ Medizininformatik-Initiative. Package mii-kerndatensatzmodul-molekulares-tumorboard#2026.0.0 based on FHIR 4.0.1. Generated 2026-02-09
Links: Table of Contents |
QA Report